Vanguard Group Inc Amneal Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 15,762,727 shares of AMRX stock, worth $117 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,762,727
Previous 14,841,969
6.2%
Holding current value
$117 Million
Previous $118 Million
12.37%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AMRX
# of Institutions
244Shares Held
136MCall Options Held
302KPut Options Held
103K-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$91.5 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$83.7 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$79.7 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$55.6 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.1MShares$37.9 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.12B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...